Podocyte p53 Limits the Severity of Experimental Alport Syndrome.

Podocyte p53 Limits the Severity of Experimental Alport Syndrome.

Item
http://www.wikidata.org/entity/Q36417903
Autophagy is involved in mouse kidney development and podocyte differentiation regulated by Notch signalling.p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO.Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome.Bromide supplementation exacerbated the renal dysfunction, injury and fibrosis in a mouse model of Alport syndrome.Endothelin A receptor activation on mesangial cells initiates Alport glomerular disease.Pathogenicity of a Human Laminin β2 Mutation Revealed in Models of Alport Syndrome.STAT3 inhibition attenuates the progressive phenotypes of Alport syndrome mouse model.Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model.Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis
P2860

Podocyte p53 Limits the Severity of Experimental Alport Syndrome.

Item
http://www.wikidata.org/entity/Q36417903
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Podocyte p53 Limits the Severity of Experimental Alport Syndrome.
@ast
Podocyte p53 Limits the Severity of Experimental Alport Syndrome.
@en
type
label
Podocyte p53 Limits the Severity of Experimental Alport Syndrome.
@ast
Podocyte p53 Limits the Severity of Experimental Alport Syndrome.
@en
prefLabel
Podocyte p53 Limits the Severity of Experimental Alport Syndrome.
@ast
Podocyte p53 Limits the Severity of Experimental Alport Syndrome.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Podocyte p53 Limits the Severity of Experimental Alport Syndrome
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932